…will hopefully yield more conclusive results. [The material in this blog post is also covered in this video. The Oxford/AstraZeneca phase I/II clinical trial was also discussed on TWiV 644.]…
…cleaves it, which activates a fluorescent marker attached to the probe. The use of this fluorescent probe allows for monitoring of the fluorescent signal quantitatively in real time rather than just detecting…
…only 76% met the Oxford case definition, which requires six months of fatigue and no other symptoms, and 52% met the CDC criteria, which require six months of fatigue plus…
…diagnosed themselves is unknown. At three months, six months, and 12 months, respectively, the number of participants responding to the questionnaires dropped to 80, 70, and 64. This represents a…
…these mouse experiments can be duplicated in humans, ChAd-SARS-CoV-2-S would clearly be superior to other SARS-CoV-2 vaccine candidates. [The material in this blog post is also covered in this video.]…
…months of fatigue and no other symptoms, and 52% met the CDC criteria, which require six months of fatigue plus four of eight other symptoms. Hm. That’s odd. The 2007…
